CORT

Corcept Therapeutics Incorporated

Price

$119.02

return (12m)

69.57%

p/e

214.66

p/bv

16.79

DIVIDEND YIELD

0.00%

CORT price

Corcept Therapeutics

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment CORT

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

25.55%

3 months

99.40%

1 year

69.57%

2 years

245.29%

5 years

477.77%

10 years

0.00%

Asset Comparator

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Fundamentals CORT

Valuation

P/E

214.66

Sector -2.19

Industry 1.21

P/BV

16.79

Sector 2.22

Industry 2.11

P/Revenue (PSR)

14.26

Sector 2.01

Industry 0.78

EV/EBITDA

273.69

Sector -17.81

Industry -25.30

EV/EBIT

279.39

Sector -26.72

Industry -18.04

P/EBITDA

1,341.69

Sector 0.36

Industry 0.18

P/EBIT

1,848.23

Sector -3.34

Industry 1.26

P/Total Assets

13.33

Sector 1.23

Industry 0.86

P/Net Current Assets

46.14

Sector -27.35

Industry -12.37

P/Working Capital

41.44

Sector -4.54

Industry -49.48

EPS

0.53

Sector -0.87

Industry -0.55

BVPS

6.72

Sector 3.80

Industry 5.36

Efficiency

Gross Margin

98.31%

Sector 43.36%

Industry 31.53%

EBITDA Margin

16.46%

Sector -323.65%

Industry -73.39%

EBIT Margin

16.12%

Sector -194.57%

Industry -11.94%

Operating Margin

0.77%

Sector -24.37%

Industry -9.87%

Net Profit Margins

6.64%

Sector -28.88%

Industry -19.76%

Asset Turnover

0.29

Sector 0.12

Industry 0.22

Profitability

ROE

7.82%

Sector -33.82%

Industry -37.56%

ROA

6.21%

Sector -29.63%

Industry -17.56%

ROIC

30.71%

Sector -431.16%

Industry -111.59%

Dividends

Dividend yield

0.00%

Sector -

Industry -

Payout

0.00%

Sector -

Industry -

Debt

Current Ratio

2.86

Sector 1.84

Industry 1.14

Net Debt / EBITDA

-7.31

Sector -1.47

Industry -31.86

Net Debt / EBIT

-7.46

Sector -1.32

Industry 2.06

Net Debt / Equity

-0.44

Sector -0.35

Industry 0.14

Gross Debt / Equity

0.00

Sector 0.14

Industry 0.51

Equity/Assets

0.79

Sector 0.42

Industry 0.25

Liabilities/Assets

0.21

Sector 0.46

Industry 0.46

Growth

5Y Revenue CAGR

17.82%

Sector -

Industry -

5Y Earnings CAGR

-13.28%

Sector -

Industry -

FAIR VALUE OF Corcept Therapeutics ACCORDING TO BENJAMIN GRAHAM

Graham's Fair Value

The Fair Value formula was created by Benjamin Graham to identify stocks with appreciation potential or that are being traded for less than they are worth. Graham was one of the greatest investors in history and Warren Buffett’s mentor.

Current price

$119.02

Fair Value

$8.95

Upside Return potential.

-92.48%

See Graham's ranking

Because it considers equity value in its calculation, this formula may not work well for technology companies.

This is not a buy/sell recommendation; the fair value calculation takes into account only the formula created by Benjamin Graham, published in the book The Intelligent Investor.

Fundamentals CORT

DRAG THE FRAME TO SEE MORE DATA

Assets	Price (US$)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
CORT Corcept Therapeutics Incorporated	$119.02	65.86%	0.00%	214.66	16.79	7.82%	6.64%
LLY Eli Lilly and Compay	$1,280.34	83.05%	0.54%	39.62	31.24	78.84%	33.53%
ISRG Intuitive Surgical Inc.	$397.72	-17.36%	0.00%	45.09	7.73	17.15%	28.45%
SNY Sanofi	$45.83	-4.42%	4.04%	7.10	1.31	18.43%	13.81%
NVS Novartis AG	$160.31	31.78%	2.05%	22.57	6.87	30.41%	22.50%
TMO Thermo Fisher Scientific Inc.	$613.54	26.39%	0.30%	31.58	4.17	13.19%	15.04%
ABT Abbott Laboratories	$114.43	-11.62%	2.33%	33.60	3.57	10.61%	11.65%
MDT Medtronic PLC	$94.13	4.71%	3.10%	24.50	2.35	9.59%	13.20%
GSK GlaxoSmithKline PLC	$52.88	41.51%	3.59%	15.15	4.28	28.24%	14.54%
CVS CVS Health Corporation	$93.65	37.68%	2.73%	25.48	1.56	6.12%	1.18%
BSX Boston Scientific Corp.	$52.01	-49.87%	0.00%	18.98	0.00	-%	19.57%
TMDX TransMedics Group Inc.	$93.97	-25.21%	0.00%	20.36	5.96	29.28%	22.69%
IDXX IDEXX Laboratories Inc.	$562.20	-11.86%	0.00%	38.32	27.08	70.67%	25.03%
RMD ResMed Inc.	$230.65	-18.34%	1.07%	21.40	4.95	23.13%	26.94%
DHR Danaher Corporation	$211.50	0.79%	0.71%	35.81	2.73	7.61%	15.95%
HCA HCA Healthcare Inc.	$407.05	4.09%	0.74%	13.12	-27.97	-213.15%	8.77%
COHR Coherent Inc.	$287.47	217.68%	0.00%	79.32	5.68	7.16%	11.31%
PHG Koninklijke Philips NV	$27.62	4.58%	3.70%	20.19	1.98	9.80%	6.30%
SYK Stryker Corp.	$339.98	-9.77%	1.02%	34.97	5.44	15.55%	14.43%
INMD InMode Ltd.	$15.04	5.14%	0.00%	11.54	1.42	12.32%	20.69%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

CORT Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT Corcept Therapeutics

Corcept Therapeutics Incorporated

Average Investor10 user rating

4.0 (1 people)

United States

28 years

Founded: 1998

2004

Time since IPO - 22 years

206

Employees

Corcept Therapeutics Incorporated (United States) is listed on the Nasdaq and has a market capitalization of $11.85 billion, with shareholders equity totaling $705.78 million.

The company employs approximately 206 people and operates in the Health sector, within the Pharmaceutical Products industry.

Over the past 12 months, Corcept Therapeutics Incorporated reported $830.81 million in revenue, generating net income of $55.19 million.

Key financial metrics include a P/E ratio of 214.66, a price-to-book (P/B) ratio of 16.79, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker CORT.

Market cap

$11.85 billion

Net worth

$705.78 million

$705,780,000.00

Assets

$888.70 million

$888,700,000.00

Total Shares Outstanding

105.00 million

105,000,000

Average Daily Trading Volume

$1.15 million

$1,148,296.00

Sector

Health

Industry

Pharmaceutical Products

CORT

CORT revenue and profits

Financial Results CORT

DRAG THE FRAME TO SEE MORE DATA

CORT cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

CVS - CVS Health

$93.65 36,41% (12M)

P/E

25.48

2.73%

ROE

6.12%

P/BV

1.56

CI - Cigna

$277.45 --6,37% (12M)

P/E

10.82

2.19%

ROE

16.04%

P/BV

1.74

CNC - Centene

$64.69 120,03% (12M)

P/E

-6.48

0.00%

ROE

-22.51%

P/BV

1.46

HUM - Humana

$378.02 32,24% (12M)

P/E

36.20

0.92%

ROE

6.63%

P/BV

2.40

SNY - Sanofi

$45.83 --5,73% (12M)

P/E

7.10

4.04%

ROE

18.43%

P/BV

1.31

LLY - Eli Lilly

$1,280.34 81,92% (12M)

P/E

39.62

0.54%

ROE

78.84%

P/BV

31.24

HCA - HCA Healthcare

$407.05 --0,11% (12M)

P/E

13.12

0.74%

ROE

-213.15%

P/BV

-27.97

NVS - Novartis

$160.31 28,43% (12M)

P/E

22.57

2.05%

ROE

30.41%

P/BV

6.87